High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia

References

Page 1

	Year	Citations
Regression Models and Life-Tables D. R. Cox Journal of the Royal Statistical Society Series B (Statistical Methodology) Regression ModelsReliability EngineeringConditional LikelihoodEngineeringLife Prediction	1972	38.8K
Nonparametric Estimation from Incomplete Observations Edward L. Kaplan, Paul Meier Journal of the American Statistical Association EngineeringAgingLife PredictionRare Event EstimationMortality Rates	1958	38.7K
WHO Handbook for Reporting Results of Cancer Treatment M K Palmer British Journal of Cancer MedicineCancer ManagementOutcomes ResearchCancer TreatmentOncology	1982	2.2K
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia Robert J. Mayer, Roger B. Davis, Charles A. Schiffer, New England Journal of Medicine	1994	1.4K
Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia R Zittoun, Franco Mandelli, Roel Willemze, New England Journal of Medicine	1995	853
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B KR Rai, JF Holland, O Glidewell, Blood	1981	447
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B KR Rai, JF Holland, O Glidewell, Blood Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematology	1981	416
HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA? RobertPeter Gale, RichardE. Champlin The Lancet TransplantationMarrow TransplantationBone Marrow FailureStem Cell TransplantationHematology	1984	272
Varying intensity of postremission therapy in acute myeloid leukemia PA Cassileth, Elizabeth Lynch, JD Hines, Blood	1992	261
Varying intensity of postremission therapy in acute myeloid leukemia PA Cassileth, Elizabeth Lynch, Hines Jd, Blood	1992	230

Page 1